Abstract
NF-Y, a trimeric transcription factor (TF) composed of two histone-like subunits (NF-YB and NF-YC) and a sequence-specific subunit (NF-YA), binds to the CCAAT motif, a common promoter element. Genome-wide mapping reveals 5000–15,000 NF-Y binding sites depending on the cell type, with the NF-YA and NF-YB subunits binding asymmetrically with respect to the CCAAT motif. Despite being characterized as a proximal promoter TF, only 25% of NF-Y sites map to promoters. A comparable number of NF-Y sites are located at enhancers, many of which are tissue specific, and nearly half of the NF-Y sites are in select subclasses of HERV LTR repeats. Unlike most TFs, NF-Y can access its target DNA motif in inactive (nonmodified) or polycomb-repressed chromatin domains. Unexpectedly, NF-Y extensively colocalizes with FOS in all genomic contexts, and this often occurs in the absence of JUN and the AP-1 motif. NF-Y also coassociates with a select cluster of growth-controlling and oncogenic TFs, consistent with the abundance of CCAAT motifs in the promoters of genes overexpressed in cancer. Interestingly, NF-Y and several growth-controlling TFs bind in a stereo-specific manner, suggesting a mechanism for cooperative action at promoters and enhancers. Our results indicate that NF-Y is not merely a commonly used proximal promoter TF, but rather performs a more diverse set of biological functions, many of which are likely to involve coassociation with FOS.
Transcriptional regulatory proteins and the RNA polymerase II (Pol II) machinery recruit chromatin-modifying activities to their target loci, thereby determining the genomic pattern of histone modifications and nucleosome occupancy. Activator proteins, functioning combinatorially at distal enhancers and in proximity to core promoters, recruit nucleosome remodeling and histone acetylase complexes, thereby generating nucleosome-depleted regions that nevertheless have peaks of histone acetylation. The Pol II machinery recruits H3K4 histone methylases near the core promoter, and upon transcriptional elongation recruits H3K36 and H3K79 histone methylases to active coding regions. Although less well defined, other DNA-binding proteins and nascent RNA can recruit H3K27 or H3K9 methylases to other genomic regions, resulting in heterochromatic silencing by polycomb complexes (PcG) or HP1, respectively.
As a consequence of the above and other mechanistic relationships between TFs and chromatin-modifying activities, the genome-wide pattern of histone modifications and nucleosome occupancy can be used to classify promoters, enhancers, insulators, and distinct types of heterochromatic regions in a given cell type under a given physiological condition. Using chromatin immunoprecipitation (ChIP), formaldehyde-assisted isolation of regulatory elements (FAIRE), and DNase I hypersensitivity techniques coupled to massively parallel DNA sequencing, such classification of functional genomic regions has been done in several cell lines in the context of ENCODE (The ENCODE Project Consortium 2004, 2007, 2011, 2012). In addition, ENCODE has performed genome-wide mapping of binding sites for ∼80 TFs (at the time of writing), most notably in the leukemia cell line K562. These genome-wide maps provide an invaluable resource for uncovering new functional aspects of individual TFs.
NF-Y (also known as CBF, CP1) is a heterotrimeric, DNA-binding TF that is conserved in all eukaryotes (Romier et al. 2003). NF-Y binds specifically to the CCAAT motif (Sinha et al. 1995; Bi et al. 1997) that is frequently found in eukaryotic promoters (Suzuki et al. 2001; Marino-Ramirez et al. 2004). The NF-YB and NF-YC subunits (protein products of NFYB and NFYC) contain histone-fold domains (HFDs) structurally related to H2B and H2A, respectively (Baxevanis et al. 1995), which mediate formation of a stable histone-like heterodimer (Romier et al. 2003). NF-YA (protein product of NFYA) binds to this heterodimer, such that the resulting heterotrimeric complex can bind specifically to the CCAAT motif (Sinha et al. 1995). NF-YA contains the sequence-specific CCAAT recognition domain, and NF-YB and NF-YC also contact DNA through their HFDs (Kim et al. 1996; Sinha et al. 1996; Zemzoumi et al. 1999). All bases of the core pentanucleotide are critical for NF-Y binding, with immediate flanking sequences on both ends also being important for efficient DNA binding in vitro (Hooft van Huijsduijnen et al. 1987; Kim et al. 1990) and in vivo (Testa et al. 2005; Ceribelli et al. 2006, 2008).
At many promoters, the CCAAT motif is highly positioned ∼80 bp upstream of the transcriptional start site (TSS), in either orientation, suggesting that its location is important for gene expression. In essentially all promoters tested, mutation of the CCAAT motif reduces or eliminates transcriptional activity (Dolfini et al. 2009). In addition, functional inactivation of NF-Y subunits or the use of a dominant-negative NF-YA mutant indicates that NF-Y binding is important for the pattern of histone modifications at promoters (for review, see Dolfini et al. 2012). Interestingly, bioinformatic studies comparing gene expression patterns in tumors vs. normal tissues indicate that NF-Y sites are highly enriched in promoters of genes overexpressed in tumors (Rhodes et al. 2005; Sinha et al. 2008; Goodarzi et al. 2009), particularly in the most aggressive cohorts. The importance of NF-Y is further underscored by the early embryonic lethality of an NF-YA mouse knockout model due to defects in cell proliferation and extensive apoptosis (Bhattacharya et al. 2003).
Here we describe the genome-wide analysis of NF-Y binding in three tumor cell lines. Using data generated by ENCODE, we analyze the bound loci with respect to chromatin states and binding by 78 chromatin-associating factors. Our results uncover many new and unexpected aspects of NF-Y biology.
Results and Discussion
Unbiased genome-wide identification of NF-Y binding sites
We performed ChIP with anti-NF-YA and anti-NF-YB antibodies in three cell types (K562, GM12878, and HeLa S3) followed by deep DNA sequencing. Antibodies (Dolfini et al. 2009) were validated by Western blot and IP-WB, showing that NF-YA and NF-YB are specifically recognized (Supplemental Fig. 1A,B). Immunoprecipitated DNA was validated on known NF-Y targets (Supplemental Fig. 1C,D) and the reproducibility between biological replicates was high (Pearson correlations: >0.8).
Using a stringent cut-off (P-value < 10−9), we identify 12655, 7932, and 5457 NF-YB binding sites and 4726, 289, and 3726 NF-YA binding sites in K562, GM12878, and HeLa S3 cells, respectively (Fig. 1A). Applying the de novo motif discovery tool MEME to NF-YB peaks in K562 cells, we identify an NF-Y binding motif (Fig. 1B) that corresponds well to the motif derived from ChIP-chip experiments (Dolfini et al. 2009). These high-confidence binding sites, 83% of which have at least one CCAAT motif within each site (with a mean of 1.7 motifs per site), will be used for subsequent bioinformatic analyses. At lower stringency, we identify 14,772 (P < 10−7) and 18,523 (P < 10−5) NF-YB sites in K562, 81% and 77% of which, respectively, have CCAAT motifs. NF-YB sites with relatively high P-values in the range from 10−5 to 10−7 contain CCAAT motifs at a rate of ∼60%, whereas the genomic background is ∼5% for similarly sized regions (Supplemental Fig. 2A). Based on these observations and a peak saturation analysis (Supplemental Fig. 2B), we estimate that there are an additional ∼4000 low-affinity NF-Y binding sites in the genome of K562 cells.
The apparently higher number of NF-YB sites with respect to NF-YA sites could be due to target loci bound only by NF-YB. In this regard, in nuclei, NF-YB is more abundant than NF-YA, and NF-YB is present in certain post-mitotic cells whereas NF-YA is not detected (Dolfini et al. 2012). However, the NF-YA and NF-YB data sets are highly correlated (Pearson correlation ∼0.7) (Fig. 1C), and quantitative PCR analysis of individual sites reveal threefold higher enrichments for NF-YB than for NF-YA. Furthermore, analysis of 21 NF-YB sites that appear to lack NF-YA show low occupancy of NF-YB, such that an NF-YA peak was below the detection limit (Supplemental Fig. 3A,B). These results indicate that the NF-YB antibody is more “immuno-efficient” than the NF-YA antibody, and that there are few, if any, genomic sites that are bound by NF-YB, but not NF-YA. For this reason, we will use the NF-YB data set to define NF-Y binding sites in subsequent analyses.
Approximately 39% of NF-Y sites are occupied in at least two cell types, whereas the remaining are cell-type specific (Fig. 1D). In accord with this observation, examination of 14 NF-Y target genes identified previously in different cell lines (Ceribelli et al. 2008) revealed that 13 are bound in K562 and eight are bound in Hela S3. We validated the cell-type specificity of a small number of these loci by ChIP-qPCR (Fig. 1E).
Asymmetric binding of NF-YA and NF-YB to the CCAAT motif
Linking the high-resolution positioning data of NF-Y subunits to the CCAAT motif, we confirm that NF-YA binds directly over the CCAAT sequence (Fig. 2A). Interestingly, the NF-Y complex is asymmetric, with NF-YB binding ∼15 bp downstream from the CCAAT motif, as defined by the CCAAT strand (Fig. 2A). This asymmetry fits extremely well with the available biochemical knowledge of NF-Y/DNA contacts (Dolfini et al. 2009) and with the crystal structure of trimer interactions with DNA (Romier et al. 2003; Nardini et al. 2013).
NF-Y targets cell signaling, DNA repair, cell-cycle, metabolic, and gene expression genes
GREAT gene ontology analysis of NF-Y bound loci from K562, GM12878, and HeLa S3 reveals a strong enrichment of genes involved in cell-signaling pathways (ITGA2B, MAPK12, MAPK13), cell cycle (G2/M checkpoints, regulation of DNA replication), DNA repair (homologous recombination and base excision), and metabolism (cholesterol biosynthesis, polyamines) (Supplemental Fig. 4A,B). The connection to the cell cycle and metabolism are in line with previous findings, and further stress the central role of NF-Y in growth-controlling decisions.
In addition, just below our fold-enrichment cutoff, we found a preponderance of GO terms associated with gene expression, in multiple cell lines, that were highly significant. Upon further analysis, it was apparent that NF-Y significantly targeted genes involved in transcription, mRNA splicing, mRNA editing, mRNA 3′-end processing, and mRNA transport. Included is a large and diverse set of TFs, including the NF-Y genes themselves, members of the transcriptional machinery, and coactivators and corepressors (Supplemental Fig. 5A,B; Supplemental Data Tables 10,11,12). Thus, NF-Y appears to be a regulator of gene expression regulators.
In a separate analysis (IPA, Ingenuity) of signaling pathways, we found that NF-Y preferentially associates with genes involved in the interrelated TP53 (protein product of TP53, also known as p53) and TNF-related apoptosis-inducing ligand (TRAIL) pathways (Supplemental Fig. 5C,D). This observation reinforces the notion of a direct and indirect NF-Y/TP53 interplay, with opposing functional consequences depending on the TP53 status of the cell, i.e., proliferation or apoptosis (Imbriano et al. 2012). In addition, it is consistent with anecdotal evidence about the role of NF-Y in apoptosis (Morachis et al. 2010; Hughes et al. 2011), which helps explain the phenotypes of NF-YA overexpression and inactivation experiments (Gatta and Mantovani 2011).
NF-Y binds to a diverse set of genomic features including nongenic regions
We annotated the NF-Y bound regions in K562 to RefSeq genes, TSSs, maps of histone modifications and nucleosome-depleted regions, and RNA levels. Unexpectedly, ∼25% of the NF-Y binding sites are not situated near RefSeq promoters, or the following types of genic regions: lncRNAs (Khalil et al. 2009); miRBASE (Kozomara and Griffiths-Jones 2011); UCSC RNA genes (Fujita et al. 2011); NONCODE (He et al. 2008); loci bound by Pol II or Pol III (Moqtaderi et al. 2010). These sites are not false positives, because the vast majority (88%) have CCAAT motifs, and 46% of them are present in at least one other cell type. Based on the patterns of colocalized histone modifications and Pol II, NF-Y-bound regions in K562 and HeLa S3 reproducibly partition into 20 clusters that can be grouped into five major classes: promoter, enhancer, gene body, PcG repressed, and LTR/nonmodified-chromatin. As discussed below, these results indicate that NF-Y binding is prevalent in tissue-specific enhancers and specific types of repetitive sequences, in addition to proximal promoters, where NF-Y has traditionally been observed.
Only a minority of NF-Y binding sites are located at proximal promoter regions
Although NF-Y is typically described as a factor that binds to proximal promoter regions, only 22% of NF-Y sites are located within 1 kbp upstream of a RefSeq TSS (Fig. 2B; Supplemental Fig. 6). A similar analysis shows ∼30% of NF-Y sites are located within chromatin states marked by histone modifications characteristic of promoters (Fig. 2C). This is consistent with our previous analysis of 2% of the human genome (Ceribelli et al. 2008). For such proximal promoter binding sites, a frequency distribution plot of peak summits indicates that NF-Y is highly positioned upstream of the TSS at −40 to −100 bp (Fig. 2D), in line with the position of the CCAAT motif at TSSs (Fig. 2E), in agreement with previously published observations (Dolfini et al. 2009). Though NF-YA and NF-YB bind asymmetrically to the CCAAT motif, the orientation with respect to the TSS is largely irrelevant for transcription, as only a small difference in the frequency of CCAAT and its complement ATTGG are noticed on the same strand (Fig. 2E). More generally, only a third of NF-Y loci (clusters B, K, L, N, P, S, U, V; n = 4061) (Fig. 3A) are associated with active promoters, as defined by high levels of di- and trimethylated H3K4, acetylated H3K27 and H3K9, Pol II, and nucleosome depletion (defined by a “valley” of low enrichment of mono-methylated H3K4 at NF-Y summits and a FAIRE signal) (Fig. 3A,B). By comparison, essentially no sites are located within nonmodified chromatin regions, and only a few MYC sites are located within weak enhancer-like regions (low K4me1 signals; Supplemental Fig. 7).
A subset of NF-Y sites is located at tissue-specific enhancers
Although NF-Y is typically described as a proximal promoter factor, binding to enhancers has been described, e.g., the 5′ upstream regions of the MHC class II genes (Dorn et al. 1988) and the intronic enhancer of the HOXB4 gene (Gilthorpe et al. 2002). In this regard, all four enhancer chromatin states, as defined by Ernst et al. (2011), are bound by NF-YB (Fig. 2C), totaling 25% of NF-Y peaks in K562. From clustering analysis of histone modifications and Pol II, 12% of all NF-Y sites (clusters E, R, and T; n = 1525) have histone modification patterns typical of enhancers: high H3K4me1, low H3K4me2/me3, low Pol II, and only a modest overlap with RefSeq TSSs (Fig. 3A,B). This is also observed with NF-Y sites in HeLa S3 (Supplemental Fig. 8). The apparent discrepancy in the NF-Y sites in K562 designated as enhancer (25% vs. 12%) is likely due to our more conservative definition of enhancer and wider region used for interpretation. Clusters E and R (Fig. 3A) are exceptional in that they represent NF-Y sites located close to (∼2.5 kb), but not within regions of high enrichment for H3K27ac, H3K9ac, H3K4me1/me2/me3 (i.e., strong actively transcribing promoters), unlike all other clusters from the enhancer and promoter groups, where NF-Y is directly within the domains enriched for acetylation and methylation.
Interestingly, cell-type-specific NF-Y sites are enriched for enhancers and are, on average, located further away from TSSs as compared with NF-Y sites common to all cell types (Supplemental Fig. 9A,B). GO analysis of cell type-specific NF-Y loci reveals categories enriched in individual cell types. NFkappaB cascade and regulation of IL12 is enriched in GM12878, a cell type in which NFkappaB is constitutively active (Gubler et al. 1991; Wolf et al. 1991), and HeLa S3 shows enrichment for epidermis morphogenesis and establishment of tissue polarity, commonly associated with cells of epithelial origin (Supplemental Fig. 4B).
Functional inactivation of NF-YA supports a transcriptional role for NF-Y located distally to TSSs
The large number of NF-Y locations at distal enhancers that are functional as defined by the histone modification pattern (Fig. 2C) and previous analysis of individual genes (Dorn et al. 1988; Gilthorpe et al. 2002) strongly suggests that NF-Y binding to distal locations can have functional consequences. To provide additional evidence for this idea, we performed expression array analysis on HeLa S3 cells depleted for NF-YA by lentiviral small hairpin RNA (shRNA) (Supplemental Fig. 10A,B) and correlated these changes to the location of NF-Y (Supplemental Figs. 10C, 11A,B). At a P-value cutoff of 10−4, 84 genes are down-regulated and 252 genes are up-regulated (Supplemental Fig. 10C) upon NF-YA knockdown. Of these, only 11% (n = 9) and 39% (n = 98) have NF-Y bound to their proximal promoters, respectively. The topmost differentially down- and up-regulated genes both trend toward having a higher percentage of their promoters occupied by NF-Y than nondifferentially regulated genes (Supplemental Fig. 11A). Of the 1059 NF-YA peaks in HeLa S3 located within 250 bp of a RefSeq TSS, only 5.2% are differentially regulated at a P-value of 10−4 (n = 55). The low percentage of differentially regulated genes bound by NF-Y is similar to that found with other TFs (Yang et al. 2006; Strub et al. 2011; Martynova et al. 2012) and could be exacerbated by the incomplete functional inactivation of NF-Y.
We ranked NF-Y sites by the fold change in RNA expression of the nearest associated gene upon NF-YA inactivation. Importantly, for both promoters and distal regions, the topmost differentially down- and up-regulated genes both trend towards having a higher percentage of NF-Y occupancy than nondifferentially regulated genes (Supplemental Fig. 11A). In addition, the most strongly down-regulated genes have NF-Y sites that are much more distal to the TSS, with the median distance being >10 kb; this preference for distal sites is not true for MYC (Supplemental Fig. 11B). This observation suggests the possibility that distal NF-Y sites might be more important for differential regulation. Whatever the relative importance of NF-Y at promoters and enhancers, our results support the idea that NF-Y located at both promoters and enhancers can be important for transcription of neighboring genes.
LTRs are the most prevalent class of NF-Y sites in the human genome
Of all NF-Y binding sites in K562, 40% directly overlap an LTR, the promoter elements of endogenous retroviruses, making LTRs the most prevalent class of NF-Y loci in the human genome (Fig. 4A). NF-Y selectively associates with the MLT1 and LTR12 families of LTRs (Fig. 4B,C). NF-Y does not bind to all LTR families, irrespective of the presence of a CCAAT motif in the consensus sequence. The R66 tandem repeat (which is related to LTR12B) (Benachenhou et al. 2009a,b), MER51A and MER51E are also associated with NF-Y. In general, there is no significant cell-type specificity in LTR binding (Supplemental Fig. 12).
Most NF-Y bound sites at LTRs lack any detectable histone modifications within 5 kbp of the NF-Y peak summit (Figs. 3A,B, 4D, clusters D and J) . These NF-Y loci appear to be inactive, yet maintain substantial NF-Y occupancy. In contrast, a sizeable minority of LTRs (27% K562; 20% GM12878) (Fig. 4D) are associated with high levels of H3 acetylation and/or H3K4 methylation and appear to be transcriptionally active. This minority class most likely represents NF-Y-bound functional regulatory elements derived from transposable repetitive elements and regulating endogenous genes.
LTRs function as promoter elements of endogenous retroviruses and they can act as regulatory elements for certain host genes (Bourque 2009). NF-Y sites abound in viral LTRs (Graves et al. 1986; Dutta et al. 1990; Faber and Sealy 1990; Greuel et al. 1990; Scheef et al. 2002). The selectivity for the gamma-retrovirus LTR family, and within it for certain members, likely reflects the presence of CCAAT in the original viral LTRs. Thus, our results suggest a strong genetic pressure on their genomic transduced copies to maintain NF-Y binding. This is not unprecedented, as evidenced by the preference of particular TFs for specific repetitive sequences (Bourque et al. 2008; Kunarso et al. 2010). Genetic analysis of the ERV-9/LTR12 element located 5′ of the globin locus-control region indicates a crucial role of the 14 CCAAT and GATA containing E3 repeats for expression of the β-globin locus (Yu et al. 2005; Pi et al. 2010). Despite this precedent, most NF-Y sites are associated with heterochromatin-like domains and are apparently devoid of any transcriptional signal. As the vast cohort of endogenous LTR proviral sites are under strong control by the host organism and, in most cases, actively repressed (Bourque 2009), we are tempted to speculate that NF-Y plays a role in the repression of these LTRs in somatic tissue and/or in their activation during embryogenesis, where many repetitive elements are demethylated and become expressed (Maksakova et al. 2008).
NF-Y binds CCAAT motifs in nonmodified chromatin domains in vivo, unlike most TFs
The majority of NF-Y sites (n = 6169; 49%) are in two similar clusters (D and J, i.e., LTR/nonmodified-chromatin class in Fig. 3A,B) that display no positive or repressive histone modifications tested for, negligible Pol II and polyA RNA, and overlap few open regulatory regions (11%, 25%) and RefSeq TSSs (7%, 11%). An analysis of MYC sites reveals the absence of binding at nonmodified chromatin sites (Supplemental Fig. 7). Interestingly, most of these loci overlap LTRs, 58% and 82%, respectively (Fig. 3B). These NF-Y sites are interesting, as most TFs are believed to not be able to bind to their DNA motifs within closed, transcriptionally inactive chromatin domains.
To further explore this issue, we calculated the percentage of motifs residing within NF-Y peaks within distinct chromatin states, over a range of motif quality scores. Interestingly, and unlike other TFs such as E2Fs and MYC, NF-Y is not excluded from any chromatin state assayed (Fig. 5A,B). At strong and weak promoters, >80% of CCAAT motifs (scores >16) are occupied by NF-Y (Fig. 5A). CCAAT motifs at enhancers and insulators are also well occupied by NF-Y (30%–75%, respectively) (Fig. 5A), although the percent occupancy is lower than at strong promoters, indicating that binding to these genomic regions is more selective. More generally, CCAAT motifs situated within open chromatin regions, as defined by FAIRE, are exceptionally well occupied to near-saturated levels by NF-Y, with 80% occupancy (Fig. 5A). Interestingly, many CCAAT motifs within the nonmodified chromatin, PcG repressed and transcription elongation states are occupied by NF-Y at a rate of ∼20% (Fig. 5A).
To test whether the substantial occupation of CCAAT motifs within nonmodified chromatin and repressed genomic contexts is unique to NF-Y, we performed the same analysis on 22 additional TFs, whose binding sites in K562 cells have been determined by ENCODE. As expected, most TFs show high levels of motif occupancy at nucleosome-depleted regulatory regions at high levels, comparable to that of NF-Y (Fig. 5C; Supplemental Fig. 13). In contrast, GATA1 and GATA2, thought to be “pioneer” TFs (Magnani et al. 2011; Zaret and Carroll 2011), are highly selective and unable to saturate their motifs that reside within these nucleosome-depleted regulatory regions. However, most TFs lack the ability to occupy even their highest quality motifs within nonmodified and repressed chromatin states. For the 23 factors tested, only USF1, MAFK, and NF-Y can bind to motifs in the context of nucleosomes lacking some of the most common “positive” histone modifications or containing the repressive H3K27me3 mark.
By preventing accessibility to target sites, chromatin is a formidable barrier for binding by most TFs. This creates a dilemma as to how cis-regulatory motifs can provide transcriptional competency if they cannot be accessed by their corresponding TFs. There are a small number of “pioneer” factors that can efficiently bind to their DNA motif located within nonmodified, closed chromatin. Once bound, these pioneer TFs can recruit chromatin-modifying activities to generate open chromatin for the subsequent binding of partnering TFs (Magnani et al. 2011; Zaret and Carroll 2011). NF-Y can associate with a CCAAT motif after nucleosome assembly in vitro, and the NF-YB/NF-YC HFD dimer can physically interact with H3/H4 in solution and on DNA (Caretti et al. 1999). Indeed, NF-Y binding is not mutually exclusive with nucleosomes in vitro, giving NF-Y the theoretical functional ability to interact efficiently with chromatin-bound CCAAT motifs in vivo. NF-Y binds to a sizeable number of sites either in functionally “hostile” environments or sites lacking all of the common positive histone modifications. Perhaps the structural features of the HFD heterodimer are instrumental for this. We propose that NF-Y is a type of “pioneer” TF that retains histone-like features while possessing high-sequence specificity, with the ability to access its motif irrespective of the chromatin state.
NF-Y extensively coassociates with FOS, typically at loci lacking an AP-1 motif
Unexpectedly, we observe a remarkable coassociation of NF-Y and FOS (Pearson = 0.74) that is only marginally lower than that observed between the NF-Y subunits (Pearson = 0.77) (Fig. 6A). This coassociation is observed over all chromatin states, cluster classes, and genic features, with 45% of NF-Y sites directly overlapping a FOS site and 39% of FOS sites directly overlapping an NF-Y site (Fig. 6B). Similar results are observed in HeLa S3 cells, although the overlap is slightly lower (26% and 16%, respectively). Interestingly, NF-Y does not significantly coassociate with JUN (Pearson = 0.14), a TF that forms heterodimers with FOS (Fig. 6A). NF-Y and FOS sites are located just as close (<50 bp) as that observed between the NF-Y subunits or between FOS and JUN (Fig. 6C). Interestingly, most sites bound by NF-Y and FOS lack detectable AP-1 motifs (Fig. 6D), with the notable exception being sites at LTR loci (see below). In contrast, and as expected, most sites bound by FOS and JUN have an AP-1 motif (Fig. 6D). A representative example of the interplay is shown in Figure 6E.
NF-Y and FOS protein–protein interactions have not been described, but the striking colocalization of these factors suggests the possibility of a direct interaction in the context of chromatin. Alternatively, the coassociation at genomic sites in vivo may not be due to a direct interaction between these factors. In this regard, ChIP-seq analysis reveals that sites bound by JUN N-terminal kinases (JNKs) generally lack AP-1 motifs, but often contain CCAAT motifs (Tiwari et al. 2012). Furthermore, NF-Y is necessary for the JNK association with these genomic sites. We speculate that FOS, together with another protein(s) such as JNK, binds to NF-Y at CCATT motifs in the context of chromatin.
NF-Y coassociates with different TFs depending on genomic context
Given the availability of 78 ChIP-seq data sets in K562 for chromatin associating factors involved in diverse functions, we explored combinatorial genomic interactions of these factors with NF-Y on promoters and enhancers. On a pairwise basis, we observe coassociation between NF-Y and 44 factors at promoters and 50 factors at enhancers (P < 10−10, Supplemental Fig. 14A), consistent with the general requirement for multiple TFs to stimulate transcription in mammalian cells. Hierarchical clustering (Supplemental Fig. 14B), and analysis of higher order combinations of factors (Supplemental Fig. 14C), reveals distinct groups of factors at proximal promoters and enhancers. At promoters, the core group of NF-Y coassociating factors includes FOS, CHD2, TBP, Pol II, CCNT2, HMGB2, MYC, and E2F4/-6 (Supplemental Fig. 14B). A comparison of promoters that are or are not bound by NF-Y reveals that only FOS and (to a lesser extent) CHD2 are specifically associated with NF-Y. FOS associates with 59% of promoters bound by NF-Y, but only 8% of promoters not bound by NF-Y. The other factors were common promoter bound TFs (Supplemental Fig. 14C). At enhancers, NF-Y forms a well-defined cluster consisting of FOS, USF1/2, MAX, CHD2, and E2F4 (Supplemental Fig. 14B), a slightly different grouping compared with promoters. FOS and USF1 are highly prevalent, being present, respectively, at 39% and 27% of NF-Y enhancers, and were the most common 2-way overlap at 13% (Supplemental Fig. 14C). A summary of the interactions at promoters and enhancers is shown in Figure 7.
The widespread partnership of NF-Y with a group of TFs (FOS, MYC, and E2Fs) that control cellular proliferation and play important roles in cancer are consistent with the importance of NF-Y for expression of growth-regulating genes. The close association of the E2Fs and NF-Y is consistent with the high enrichment of their motifs at promoters of genes overexpressed in tumors (Rhodes et al. 2005; Sinha et al. 2008; Goodarzi et al. 2009). In addition, apoptosis mediated by overexpression of NF-Y is abolished in cells lacking E2F1 (Gurtner et al. 2010). E2F4 is part of the DREAM complex (Litovchick et al. 2007; Schmit et al. 2007), which binds to the CDE motif, and cooperates with the CCAAT motif to negatively regulate expression of G2/M-specific genes during the cell cycle (Muller and Engeland 2010; Muller et al. 2012). CCAAT motif and CDE containing G2/M genes are significantly overexpressed in a model of stepwise transformation of primary fibroblasts (Tabach et al. 2005).
Essentially, all E box binding TFs present in ENCODE are statistically enriched at NF-Y locations (Supplemental Fig. 14A), suggesting a pervasive partnership between CCAAT and E boxes. Interestingly, the number of MYC/NF-Y bound promoters exceeds those with MAX/NF-Y, suggesting that either MYC heterodimerizes with another E box binding partner, or that it binds in an E box-independent manner, possibly directly to NF-Y (Izumi et al. 2001; Ravasi et al. 2010).
At the LTR/nonmodified chromatin class, NF-Y extensively colocalizes only with FOS, USF1, and to a lesser degree, USF2 and SP1, although specific groupings occur upon clustering (Supplemental Fig. 15A). The chromatin at colocalized NF-Y/USF sites is not acetylated, suggesting that USF1 and USF2, in the context of binding with NF-Y, do not behave as barrier elements of acetylated chromatin in intergenic regions that inhibit the spread of heterochromatin (West et al. 2004; Huang et al. 2007; Li et al. 2011). It should also be noted that cluster HL2 (n = 147; Supplemental Fig. 15A) is enriched for four members of the CTCF–cohesin insulator complex (CTCF, CTCFL, RAD21, and SMC3) in direct proximity with NF-Y, and a similar small cluster is also observed in the PcG repressed class (data not shown). Interestingly, the NF-Y-bound regions in the LTR/nonmodified chromatin class show a remarkable paucity of known DNA motifs, with the exception of the CCAAT motif and in K562, but not GM12878, the KLF4 motif (P = 1.6 × 10−10; data not shown). De novo motif analysis of the same NF-Y sites again reveals the CCAAT and KLF4 motifs as well as two unknown motifs (Supplemental Fig. 15B). As KLF4 can act as a transcriptional activator or repressor (Turner and Crossley 1998; van Vliet et al. 2000; Schuierer et al. 2001; Yoon and Yang 2004; Evans et al. 2007; Oishi et al. 2008) and is expressed in K562 cells (Kalra et al. 2011), it may cooperate with NF-Y to repress LTR elements.
NF-Y sites contain positionally biased TFs
To investigate whether there is a specific distance relationship between NF-Y and coassociating factors, we plotted the distribution of the relative position of the TATA element, E box, E2F, and AP-1 motifs (termed “predicted”) at NF-Y peaks in relation to the position of the best-scoring CCAAT motif, while maintaining strandedness. We then plotted the subset of motifs (termed “verified”) that were actually occupied in vivo by the TF of interest. Remarkably, there is an AP-1 motif 10- to 11-bp upstream of CCAAT, which corresponds to verified FOS target sites (Fig. 8A). However, this positioning was only found at NF-Y-bound LTRs, as sites with NF-Y and FOS generally do not contain an AP-1 motif (Fig. 6D). The TATA element (+50), E box (−12/−11) and E2F (+6/+7, +31, +55, and +72) motifs are also highly positioned in a CCAAT orientation-specific manner (Fig. 8B). The position of the TATA element is maintained in TBP-bound locations at NF-Y sites. The E2F motif is unusual in that multiple stereo alignments are present and only one, the closest to CCAAT, is maintained at E2F6, but not at E2F4 occupied sites (Fig. 8B; data not shown). The positioning of the E box is only maintained when MAX or USF1 but not MYC loci are considered, suggesting that MYC, when associating with NF-Y, is either not positioned or does not bind DNA directly.
The USF1 observation is interesting because it is one of the few factors that partners with NF-Y in the LTR/nonmodified chromatin class and can bind its motif within a repressive nucleosomal structure. Perhaps the precise positioning may facilitate the cooperation of NF-Y and USF1 to penetrate inactive, nonmodified chromatin domains.
Cooperativity mediated by precise spacing between NF-Y and other TFs has been observed at MHC class II promoters, NF-Y/ATF6 sites in ER-stress responsive promoters (Yoshida et al. 2000), and multiple CCAAT motifs in G2/M promoters (Salsi et al. 2003). Our results greatly extend these findings of precise spacing relationships with NF-Y with its most common TF partners, notably those that play crucial roles in the control of cell proliferation, cell cycle, and metabolism genes. In the vast majority of NF-Y-bound promoters, where NF-Y synergizes with neighboring TFs, it appears to be more of a promoter organizer and facilitator of transcription than a strong activator per se. Our results strongly suggest that cooperativity mediated by precise spacing is a general mechanism utilized by NF-Y to regulate transcription of its target genes.
Conclusions
Our comprehensive analysis of NF-Y confirms many functions including its prevalence at proximal promoters, particularly those of growth controlling genes, at a much higher degree of precision and completion. More interestingly, our analyses uncover several novel and unexpected aspects of NF-Y function. In particular, NF-Y binds asymmetrically at its target sites, plays an important role at many tissue-specific enhancers, is capable of binding “closed” chromatin including at LTRs, coassociates pervasively with FOS but not other AP-1 factors, and displays precise stereo positioning with a restricted group of TFs involved in cellular proliferation. Lastly, we note that comprehensive bioinformatic analyses of the type performed here have been done on relatively few TFs. Similar analyses on other TFs whose target sites have been or will be defined by ChIP-seq are likely to uncover new functional properties and relationships of biological relevance.
Methods
Cell culture
K562, GM12878, and HeLa S3 were grown as per standard ENCODE protocols (The ENCODE Project Consortium 2011) and a detailed protocol is available at http://genome.ucsc.edu/ENCODE/.
ENCODE data sets
ChIP-sequencing data sets for histone PTMs, TFs, and RNA-seq for K562 and/or HeLa S3 cell lines were provided by ENCODE via the UCSC Genome Browser and are described there and elsewhere (The ENCODE Project Consortium 2011; http://genome.ucsc.edu/ENCODE/). ChIP-seq data sets were mapped and peaks called as described in the Supplemental Methods. RNA-seq data was prepared by Helicos as long (>200 nt), poly(A)-enriched, cytosolic RNA, and mapped using rSeq (Jiang and Wong 2008, 2009). Chromatin state maps and the associated numbering are from ENCODE and are detailed at http://genome.ucsc.edu/ENCODE/ and in Ernst et al. (2011). The chromatin state “heterochromatin” was renamed to “non-modified-chromatin.”
Lentiviral knockdown and gene expression arrays
Scrambled control (shSCM) and NF-YA pLKO.1-shRNAs were designed by Sigma-Aldrich. The puromycin resistance cassette was replaced with an EGFP cassette. Viral production and transduction were carried out as previously described (Benatti et al. 2011). HeLa S3 cells were transduced with shSCM (scrambled control) or shNF-YA viral supernatants, in triplicate, and cells were collected after 48 h of incubation. The distribution of cells within the cell cycle was checked via FACS as previously described (Benatti et al. 2011). Knockdown efficiency was assayed by PCR on cDNA to known NF-YA target genes and by Western Blot on whole-cell protein extracts using anti-NF-YA and anti-actin antibodies. For arrays, total RNA was prepared by TRIzol extraction and Qiagen RNeasy kit purification, converted to biotinylated aRNA, and hybridized to U133 Plus 2.0 GeneChip expression arrays using the 3′ IVT Express Kit (Affymetrix) following the manufacturer's protocol. Arrays were RMA normalized (Irizarry et al. 2003), gene expression levels calculated, differential expression determined, and probes annotated using the following R packages from the Bioconductor project: affy (Gautier et al. 2004), limma (Smyth 2004), and annaffy (http://www.bioconductor.org/packages/devel/bioc/html/annaffy.html).
Annotation of peaks to gene features, GO analysis (GREAT/IPA)
Genomic locations of peak summits (where summit is the local maxima in read counts) were submitted to the annotation tool GREAT (McLean et al. 2010) using the following parameters: whole-genome background set, basal plus extension, proximal upstream, 5 kbp; proximal downstream, 1 kbp; distal, 1 mbp; or whole-genome background set, basal, proximal upstream, 5 kbp; proximal downstream, 1 kbp. Molecular signaling pathways were visualized using IPA (Ingenuity Systems: http://www.ingenuity.com) where a gray-shaded node represents a K562 NF-YB binding site located within the putative regulatory region, as defined by GREAT, of that molecule. Peak summits were annotated to genomic features using in-house scripts.
Motif stereo-positioning
NF-YB summit locations from K562 were scanned using Pscan (Zambelli et al. 2009) for matches to the NF-Y matrix in the JASPAR_CORE_2009 database (MA0060.1) (Portales-Casamar et al. 2010). For NF-Y loci with the best matrix match on the positive strand, the first C (of CCAAT) of the best match was set to 0 bp. Genomic sequences ±75 bp from the motifs were retrieved and scanned with Pscan using the collection of matrices in the JASPAR_CORE_2009 database (Portales-Casamar et al. 2010). For each JASPAR matrix, only regions containing a best matrix match >0.8 (computed as described in Zambelli et al. 2009) were considered for further analyses. This population was deemed “predicted.” For each “predicted” population, the subpopulation of regions that overlapped the relevant TF ChIP-seq peak data set were deemed “ChIP verified.” The frequency of the best motif occurrences for each motif matrix at each base pair from the CCAAT motif was determined for each population and plotted as the percentage of motifs.
Histone modifications and chromatin-associated factor clustering
Density arrays at NF-YB peak summits spanning either ±5 kbp or ±500 bp representing ChIP-seq read counts of histone PTMs (H3K79me2, H3K4me3, H3K27me3, H3K4me1, H4K20me1, H3K36me3, H3K4me2, H3K9ac, H3K9me1, H3K27ac), NF-YA, NF-YB, and RNA Pol II or NF-YA, NF-YB, and 78 chromatin-associated factors (see Supplemental Fig. 15A for the full list) with appropriate input samples, were computed using the ranked based correlation method of seqMINER v1.2 (Ye et al. 2011). Clustering was carried out using the following parameters: T = 10, K-means. Clusters from three to 50 were considered. Non-normalized raw read counts are depicted in Figure 3A and Supplemental Figures 7, 8, and 15A.
Mapping to repeats
Bowtie (Langmead et al. 2009) was used to map the NF-YB and input ChIP-seq data sets to a reference genome composed of Repbase v15.08 (Jurka et al. 2005) entries—simple.ref, humrep.ref, humsub.ref, and pseudo.ref—allowing ≤2 mismatches per read, and reads with >1 alignment had one alignment selected at random. Read counts for each Repbase entry were tallied and the ChIP:input ratio calculated. Individual consensus sequences of repeat elements were scored for the presence or absence of the CCAAT motif using the matrix derived from this study and FIMO (Grant et al. 2011), with matches called at a significance P-value threshold of 10−4.
Hierarchical clustering of binding events to promoters and enhancers
Regions considered promoters and enhancers were taken from the K562 chromatin state maps of Ernst et al. (2011). Regions were considered “bound” if an NF-YB peak summit directly overlapped the region. Regions were considered “nonbound” if no NF-YB peak overlapped the region of interest and the region had <1.5× the normalized fold-over-input ChIP-seq enrichment. At all NF-YB bound or NF-YB nonbound regions, chromatin associated factors were scored as present (1) or absent (0) based on directly overlapping peak summits. The R packages pvclust (Suzuki and Shimodaira 2006) and snow (http://cran.r-project.org/web/packages/snow/) were used to cluster the matrices and to calculate P-values using multiscale bootstrap resampling. Parameters were: method.dist=”binary”, method.hclust=”ward”, nboot=10000. Red and blue numbers in plots indicate the approximately unbiased (AU) P-values and the bootstrap probability (BP), respectively, as detailed in Suzuki and Shimodaira (2006).
Statistical test of TF coassociation with NF-YB
NF-YB-bound regions were as above. We assessed promoters or enhancers occupied by NF-YB for individual co-occupancy of 78 transcriptional regulators. The significance of the overlap was tested by a 2 × 2 contingency table using Fisher's exact test and calculated (Carlson et al. 2009), and P-values <10−9 were deemed significant.
Data access
Microarray gene expression data from this study have been submitted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE40215.
Acknowledgments
The NF-Y ChIP-sequencing data was generated as part of ENCODE. We thank the members of the Snyder and Gerstein labs, and the ENCODE Project Consortium for support and access to pre-release data sets; Hannah Monahan for preparing sequencing libraries; WQCG and RITG for technical support and access to computing facilities; Koon Ho Wong, Rajani Gudipatti, Nathan Lamarre-Vincent, and Joseph Geisberg for advice and help with figures; Benoit Miotto for performing Orc2 ChIP-seq. This work was supported by grants to K.S. from the National Institutes of Health (GM30186; HG4558), to R.M. from Lombardy Region (NEPENTE) and AIRC, and to C.I. from AIRC (MFAG 6192).
Author contributions: J.D.F. and K.S. conceived the project. J.D.F., K.S., R.M., G.P., P.B., and C.I. participated in experimental design. J.D.F. performed biological experiments and analyzed the data; G.P. analyzed the motif stereo-positioning data; P.B., C.I., and J.D.F. performed shRNA experiments. J.D.F., R.M., and K.S. wrote the paper. All authors have read and accepted the manuscript.
Footnotes
[Supplemental material is available for this article.]
Article published online before print. Article, supplemental material, and publication date are at http://www.genome.org/cgi/doi/10.1101/gr.148080.112.
References
- Baxevanis AD, Arents G, Moudrianakis EN, Landsman D 1995. A variety of DNA-binding and multimeric proteins contain the histone fold motif. Nucleic Acids Res 23: 2685–2691 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Benachenhou F, Blikstad V, Blomberg J 2009a. The phylogeny of orthoretroviral long terminal repeats (LTRs). Gene 448: 134–138 [DOI] [PubMed] [Google Scholar]
- Benachenhou F, Jern P, Oja M, Sperber G, Blikstad V, Somervuo P, Kaski S, Blomberg J 2009b. Evolutionary conservation of orthoretroviral long terminal repeats (LTRs) and ab initio detection of single LTRs in genomic data. PLoS ONE 4: e5179. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Benatti P, Dolfini D, Vigano A, Ravo M, Weisz A, Imbriano C 2011. Specific inhibition of NF-Y subunits triggers different cell proliferation defects. Nucleic Acids Res 39: 5356–5368 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bhattacharya A, Deng JM, Zhang Z, Behringer R, de Crombrugghe B, Maity SN 2003. The B subunit of the CCAAT box binding transcription factor complex (CBF/NF-Y) is essential for early mouse development and cell proliferation. Cancer Res 63: 8167–8172 [PubMed] [Google Scholar]
- Bi W, Wu L, Coustry F, de Crombrugghe B, Maity SN 1997. DNA binding specificity of the CCAAT-binding factor CBF/NF-Y. J Biol Chem 272: 26562–26572 [DOI] [PubMed] [Google Scholar]
- Bourque G 2009. Transposable elements in gene regulation and in the evolution of vertebrate genomes. Curr Opin Genet Dev 19: 607–612 [DOI] [PubMed] [Google Scholar]
- Bourque G, Leong B, Vega VB, Chen X, Lee YL, Srinivasan KG, Chew JL, Ruan Y, Wei CL, Ng HH, et al. 2008. Evolution of the mammalian transcription factor binding repertoire via transposable elements. Genome Res 18: 1752–1762 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Caretti G, Motta MC, Mantovani R 1999. NF-Y associates with H3-H4 tetramers and octamers by multiple mechanisms. Mol Cell Biol 19: 8591–8603 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carlson JM, Heckerman D, Shani G 2009. Estimating false discovery rates for contingency tables. Microsoft Research Technical Reports MSR-TR-2009-53
- Ceribelli M, Alcalay M, Vigano MA, Mantovani R 2006. Repression of new p53 targets revealed by ChIP on chip experiments. Cell Cycle 5: 1102–1110 [DOI] [PubMed] [Google Scholar]
- Ceribelli M, Dolfini D, Merico D, Gatta R, Vigano AM, Pavesi G, Mantovani R 2008. The histone-like NF-Y is a bifunctional transcription factor. Mol Cell Biol 28: 2047–2058 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dolfini D, Zambelli F, Pavesi G, Mantovani R 2009. A perspective of promoter architecture from the CCAAT box. Cell Cycle 8: 4127–4137 [DOI] [PubMed] [Google Scholar]
- Dolfini D, Gatta R, Mantovani R 2012. NF-Y and the transcriptional activation of CCAAT promoters. Crit Rev Biochem Mol Biol 47: 29–49 [DOI] [PubMed] [Google Scholar]
- Dorn A, Fehling HJ, Koch W, Le Meur M, Gerlinger P, Benoist C, Mathis D 1988. B-cell control region at the 5′ end of a major histocompatibility complex class II gene: Sequences and factors. Mol Cell Biol 8: 3975–3987 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dutta A, Stoeckle MY, Hanafusa H 1990. Serum and v-src increase the level of a CCAAT-binding factor required for transcription from a retroviral long terminal repeat. Genes Dev 4: 243–254 [DOI] [PubMed] [Google Scholar]
- The ENCODE Project Consortium 2004. The ENCODE (ENCyclopedia Of DNA Elements) Project. Science 306: 636–640 [DOI] [PubMed] [Google Scholar]
- The ENCODE Project Consortium 2007. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447: 799–816 [DOI] [PMC free article] [PubMed] [Google Scholar]
- The ENCODE Project Consortium 2011. A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol 9: e1001046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- The ENCODE Project Consortium 2012. An integrated encyclopedia of DNA elements in the human genome. Nature 489: 57–74 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, Epstein CB, Zhang X, Wang L, Issner R, Coyne M, et al. 2011. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473: 43–49 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Evans PM, Zhang W, Chen X, Yang J, Bhakat KK, Liu C 2007. Kruppel-like factor 4 is acetylated by p300 and regulates gene transcription via modulation of histone acetylation. J Biol Chem 282: 33994–34002 [DOI] [PubMed] [Google Scholar]
- Faber M, Sealy L 1990. Rous sarcoma virus enhancer factor I is a ubiquitous CCAAT transcription factor highly related to CBF and NF-Y. J Biol Chem 265: 22243–22254 [PubMed] [Google Scholar]
- Fujita PA, Rhead B, Zweig AS, Hinrichs AS, Karolchik D, Cline MS, Goldman M, Barber GP, Clawson H, Coelho A, et al. 2011. The UCSC Genome Browser database: Update 2011. Nucleic Acids Res 39: D876–D882 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gatta R, Mantovani R 2011. NF-Y affects histone acetylation and H2A.Z deposition in cell cycle promoters. Epigenetics 6: 526–534 [DOI] [PubMed] [Google Scholar]
- Gautier L, Cope L, Bolstad BM, Irizarry RA 2004. affy–analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20: 307–315 [DOI] [PubMed] [Google Scholar]
- Gilthorpe J, Vandromme M, Brend T, Gutman A, Summerbell D, Totty N, Rigby PW 2002. Spatially specific expression of Hoxb4 is dependent on the ubiquitous transcription factor NFY. Development 129: 3887–3899 [DOI] [PubMed] [Google Scholar]
- Goodarzi H, Elemento O, Tavazoie S 2009. Revealing global regulatory perturbations across human cancers. Mol Cell 36: 900–911 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Grant CE, Bailey TL, Noble WS 2011. FIMO: Scanning for occurrences of a given motif. Bioinformatics 27: 1017–1018 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Graves BJ, Johnson PF, McKnight SL 1986. Homologous recognition of a promoter domain common to the MSV LTR and the HSV tk gene. Cell 44: 565–576 [DOI] [PubMed] [Google Scholar]
- Greuel BT, Sealy L, Majors JE 1990. Transcriptional activity of the Rous sarcoma virus long terminal repeat correlates with binding of a factor to an upstream CCAAT box in vitro. Virology 177: 33–43 [DOI] [PubMed] [Google Scholar]
- Gubler U, Chua AO, Schoenhaut DS, Dwyer CM, McComas W, Motyka R, Nabavi N, Wolitzky AG, Quinn PM, Familletti PC, et al. 1991. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci 88: 4143–4147 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gurtner A, Fuschi P, Martelli F, Manni I, Artuso S, Simonte G, Ambrosino V, Antonini A, Folgiero V, Falcioni R, et al. 2010. Transcription factor NF-Y induces apoptosis in cells expressing wild-type p53 through E2F1 upregulation and p53 activation. Cancer Res 70: 9711–9720 [DOI] [PubMed] [Google Scholar]
- He S, Liu C, Skogerbo G, Zhao H, Wang J, Liu T, Bai B, Zhao Y, Chen R 2008. NONCODE v2.0: Decoding the non-coding. Nucleic Acids Res 36: D170–D172 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hooft van Huijsduijnen RA, Bollekens J, Dorn A, Benoist C, Mathis D 1987. Properties of a CCAAT box-binding protein. Nucleic Acids Res 15: 7265–7282 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Huang S, Li X, Yusufzai TM, Qiu Y, Felsenfeld G 2007. USF1 recruits histone modification complexes and is critical for maintenance of a chromatin barrier. Mol Cell Biol 27: 7991–8002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hughes R, Kristiansen M, Lassot I, Desagher S, Mantovani R, Ham J 2011. NF-Y is essential for expression of the proapoptotic bim gene in sympathetic neurons. Cell Death Differ 18: 937–947 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Imbriano C, Gnesutta N, Mantovani R 2012. The NF-Y/p53 liaison: Well beyond repression. Biochim Biophys Acta 1825:131–139 [DOI] [PubMed] [Google Scholar]
- Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249–264 [DOI] [PubMed] [Google Scholar]
- Izumi H, Molander C, Penn LZ, Ishisaki A, Kohno K, Funa K 2001. Mechanism for the transcriptional repression by c-Myc on PDGF β-receptor. J Cell Sci 114: 1533–1544 [DOI] [PubMed] [Google Scholar]
- Jiang H, Wong WH 2008. SeqMap: Mapping massive amount of oligonucleotides to the genome. Bioinformatics 24: 2395–2396 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jiang H, Wong WH 2009. Statistical inferences for isoform expression in RNA-Seq. Bioinformatics 25: 1026–1032 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jurka J, Kapitonov VV, Pavlicek A, Klonowski P, Kohany O, Walichiewicz J 2005. Repbase Update, a database of eukaryotic repetitive elements. Cytogenet Genome Res 110: 462–467 [DOI] [PubMed] [Google Scholar]
- Kalra IS, Alam MM, Choudhary PK, Pace BS 2011. Kruppel-like Factor 4 activates HBG gene expression in primary erythroid cells. Br J Haematol 154: 248–259 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Khalil AM, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D, Thomas K, Presser A, Bernstein BE, van Oudenaarden A, et al. 2009. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci 106: 11667–11672 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kim CG, Swendeman SL, Barnhart KM, Sheffery M 1990. Promoter elements and erythroid cell nuclear factors that regulate α-globin gene transcription in vitro. Mol Cell Biol 10: 5958–5966 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kim IS, Sinha S, de Crombrugghe B, Maity SN 1996. Determination of functional domains in the C subunit of the CCAAT-binding factor (CBF) necessary for formation of a CBF-DNA complex: CBF-B interacts simultaneously with both the CBF-A and CBF-C subunits to form a heterotrimeric CBF molecule. Mol Cell Biol 16: 4003–4013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kozomara A, Griffiths-Jones S 2011. miRBase: Integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39: D152–D157 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kunarso G, Chia NY, Jeyakani J, Hwang C, Lu X, Chan YS, Ng HH, Bourque G 2010. Transposable elements have rewired the core regulatory network of human embryonic stem cells. Nat Genet 42: 631–634 [DOI] [PubMed] [Google Scholar]
- Langmead B, Trapnell C, Pop M, Salzberg SL 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Li X, Wang S, Li Y, Deng C, Steiner LA, Xiao H, Wu C, Bungert J, Gallagher PG, Felsenfeld G, et al. 2011. Chromatin boundaries require functional collaboration between the hSET1 and NURF complexes. Blood 118: 1386–1394 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Litovchick L, Sadasivam S, Florens L, Zhu X, Swanson SK, Velmurugan S, Chen R, Washburn MP, Liu XS, DeCaprio JA 2007. Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence. Mol Cell 26: 539–551 [DOI] [PubMed] [Google Scholar]
- Magnani L, Eeckhoute J, Lupien M 2011. Pioneer factors: Directing transcriptional regulators within the chromatin environment. Trends Genet 27: 465–474 [DOI] [PubMed] [Google Scholar]
- Maksakova IA, Mager DL, Reiss D 2008. Keeping active endogenous retroviral-like elements in check: The epigenetic perspective. Cell Mol Life Sci 65: 3329–3347 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marino-Ramirez L, Spouge JL, Kanga GC, Landsman D 2004. Statistical analysis of over-represented words in human promoter sequences. Nucleic Acids Res 32: 949–958 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Martynova E, Pozzi S, Basile V, Dolfini D, Zambelli F, Imbriano C, Pavesi G, Mantovani R 2012. Gain-of-function p53 mutants have widespread genomic locations partially overlapping with p63. Oncotarget 3: 132–143 [DOI] [PMC free article] [PubMed] [Google Scholar]
- McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT, Lowe CB, Wenger AM, Bejerano G 2010. GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol 28: 495–501 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Moqtaderi Z, Wang J, Raha D, White RJ, Snyder M, Weng Z, Struhl K 2010. Genomic binding profiles of functionally distinct RNA polymerase III transcription complexes in human cells. Nat Struct Mol Biol 17: 635–640 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Morachis JM, Murawsky CM, Emerson BM 2010. Regulation of the p53 transcriptional response by structurally diverse core promoters. Genes Dev 24: 135–147 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Muller GA, Engeland K 2010. The central role of CDE/CHR promoter elements in the regulation of cell cycle-dependent gene transcription. FEBS J 277: 877–893 [DOI] [PubMed] [Google Scholar]
- Muller GA, Quaas M, Schumann M, Krause E, Padi M, Fischer M, Litovchick L, DeCaprio JA, Engeland K 2012. The CHR promoter element controls cell cycle-dependent gene transcription and binds the DREAM and MMB complexes. Nucleic Acids Res 40: 1561–1578 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nardini M, Gnesutta N, Donati G, Gatta R, Forni C, Fossati A, Vonrhein C, Moras D, Romier C, Bolognesi M, et al. 2013. Sequence-specific transcription factor NF-Y displays histone-like DNA binding and H2B-like ubiquitination. Cell 152: 132–143 [DOI] [PubMed] [Google Scholar]
- Oishi Y, Manabe I, Tobe K, Ohsugi M, Kubota T, Fujiu K, Maemura K, Kubota N, Kadowaki T, Nagai R 2008. SUMOylation of Kruppel-like transcription factor 5 acts as a molecular switch in transcriptional programs of lipid metabolism involving PPAR-δ. Nat Med 14: 656–666 [DOI] [PubMed] [Google Scholar]
- Pi W, Zhu X, Wu M, Wang Y, Fulzele S, Eroglu A, Ling J, Tuan D 2010. Long-range function of an intergenic retrotransposon. Proc Natl Acad Sci 107: 12992–12997 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Portales-Casamar E, Thongjuea S, Kwon AT, Arenillas D, Zhao X, Valen E, Yusuf D, Lenhard B, Wasserman WW, Sandelin A 2010. JASPAR 2010: The greatly expanded open-access database of transcription factor binding profiles. Nucleic Acids Res 38: D105–D110 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ravasi T, Suzuki H, Cannistraci CV, Katayama S, Bajic VB, Tan K, Akalin A, Schmeier S, Kanamori-Katayama M, Bertin N, et al. 2010. An atlas of combinatorial transcriptional regulation in mouse and man. Cell 140: 744–752 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Barrette TR, Ghosh D, Chinnaiyan AM 2005. Mining for regulatory programs in the cancer transcriptome. Nat Genet 37: 579–583 [DOI] [PubMed] [Google Scholar]
- Romier C, Cocchiarella F, Mantovani R, Moras D 2003. The NF-YB/NF-YC structure gives insight into DNA binding and transcription regulation by CCAAT factor NF-Y. J Biol Chem 278: 1336–1345 [DOI] [PubMed] [Google Scholar]
- Salsi V, Caretti G, Wasner M, Reinhard W, Haugwitz U, Engeland K, Mantovani R 2003. Interactions between p300 and multiple NF-Y trimers govern cyclin B2 promoter function. J Biol Chem 278: 6642–6650 [DOI] [PubMed] [Google Scholar]
- Scheef G, Fischer N, Flory E, Schmitt I, Tonjes RR 2002. Transcriptional regulation of porcine endogenous retroviruses released from porcine and infected human cells by heterotrimeric protein complex NF-Y and impact of immunosuppressive drugs. J Virol 76: 12553–12563 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schmit F, Korenjak M, Mannefeld M, Schmitt K, Franke C, von Eyss B, Gagrica S, Hanel F, Brehm A, Gaubatz S 2007. LINC, a human complex that is related to pRB-containing complexes in invertebrates regulates the expression of G2/M genes. Cell Cycle 6: 1903–1913 [DOI] [PubMed] [Google Scholar]
- Schneider TD, Stephens RM 1990. Sequence logos: A new way to display consensus sequences. Nucleic Acids Res 18: 6097–6100 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schuierer M, Hilger-Eversheim K, Dobner T, Bosserhoff AK, Moser M, Turner J, Crossley M, Buettner R 2001. Induction of AP-2α expression by adenoviral infection involves inactivation of the AP-2rep transcriptional corepressor CtBP1. J Biol Chem 276: 27944–27949 [DOI] [PubMed] [Google Scholar]
- Sinha S, Maity SN, Lu J, de Crombrugghe B 1995. Recombinant rat CBF-C, the third subunit of CBF/NFY, allows formation of a protein-DNA complex with CBF-A and CBF-B and with yeast HAP2 and HAP3. Proc Natl Acad Sci 92: 1624–1628 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sinha S, Kim IS, Sohn KY, de Crombrugghe B, Maity SN 1996. Three classes of mutations in the A subunit of the CCAAT-binding factor CBF delineate functional domains involved in the three-step assembly of the CBF-DNA complex. Mol Cell Biol 16: 328–337 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sinha S, Adler AS, Field Y, Chang HY, Segal E 2008. Systematic functional characterization of cis-regulatory motifs in human core promoters. Genome Res 18: 477–488 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smyth GK 2004. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet MolBiol 3 doi: 10.2202/1544-6115.0127 [DOI] [PubMed] [Google Scholar]
- Strub T, Giuliano S, Ye T, Bonet C, Keime C, Kobi D, Le Gras S, Cormont M, Ballotti R, Bertolotto C, et al. 2011. Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma. Oncogene 30: 2319–2332 [DOI] [PubMed] [Google Scholar]
- Suzuki R, Shimodaira H 2006. Pvclust: An R package for assessing the uncertainty in hierarchical clustering. Bioinformatics 22: 1540–1542 [DOI] [PubMed] [Google Scholar]
- Suzuki Y, Tsunoda T, Sese J, Taira H, Mizushima-Sugano J, Hata H, Ota T, Isogai T, Tanaka T, Nakamura Y, et al. 2001. Identification and characterization of the potential promoter regions of 1031 kinds of human genes. Genome Res 11: 677–684 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tabach Y, Milyavsky M, Shats I, Brosh R, Zuk O, Yitzhaky A, Mantovani R, Domany E, Rotter V, Pilpel Y 2005. The promoters of human cell cycle genes integrate signals from two tumor suppressive pathways during cellular transformation. Mol Syst Biol 1: 2005.0022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Testa A, Donati G, Yan P, Romani F, Huang TH, Vigano MA, Mantovani R 2005. Chromatin immunoprecipitation (ChIP) on chip experiments uncover a widespread distribution of NF-Y binding CCAAT sites outside of core promoters. J Biol Chem 280: 13606–13615 [DOI] [PubMed] [Google Scholar]
- Tiwari VK, Stadler MB, Wirbelauer C, Paro R, Schubeler D, Beisel C 2012. A chromatin-modifying function of JNK during stem cell differentiation. Nat Genet 44: 94–100 [DOI] [PubMed] [Google Scholar]
- Turner J, Crossley M 1998. Cloning and characterization of mCtBP2, a co-repressor that associates with basic Krüppel-like factor and other mammalian transcriptional regulators. EMBO J 17: 5129–5140 [DOI] [PMC free article] [PubMed] [Google Scholar]
- van Vliet J, Turner J, Crossley M 2000. Human Krüppel-like factor 8: A CACCC-box binding protein that associates with CtBP and represses transcription. Nucleic Acids Res 28: 1955–1962 [DOI] [PMC free article] [PubMed] [Google Scholar]
- West AG, Huang S, Gaszner M, Litt MD, Felsenfeld G 2004. Recruitment of histone modifications by USF proteins at a vertebrate barrier element. Mol Cell 16: 453–463 [DOI] [PubMed] [Google Scholar]
- Wolf SF, Temple PA, Kobayashi M, Young D, Dicig M, Lowe L, Dzialo R, Fitz L, Ferenz C, Hewick RM, et al. 1991. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 146: 3074–3081 [PubMed] [Google Scholar]
- Yang A, Zhu Z, Kapranov P, McKeon F, Church GM, Gingeras TR, Struhl K 2006. Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells. Mol Cell 24: 593–602 [DOI] [PubMed] [Google Scholar]
- Ye T, Krebs AR, Choukrallah MA, Keime C, Plewniak F, Davidson I, Tora L 2011. seqMINER: An integrated ChIP-seq data interpretation platform. Nucleic Acids Res 39: e35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yoon HS, Yang VW 2004. Requirement of Krüppel-like factor 4 in preventing entry into mitosis following DNA damage. J Biol Chem 279: 5035–5041 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yoshida H, Okada T, Haze K, Yanagi H, Yura T, Negishi M, Mori K 2000. ATF6 activated by proteolysis binds in the presence of NF-Y (CBF) directly to the cis-acting element responsible for the mammalian unfolded protein response. Mol Cell Biol 20: 6755–6767 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yu X, Zhu X, Pi W, Ling J, Ko L, Takeda Y, Tuan D 2005. The long terminal repeat (LTR) of ERV-9 human endogenous retrovirus binds to NF-Y in the assembly of an active LTR enhancer complex NF-Y/MZF1/GATA-2. J Biol Chem 280: 35184–35194 [DOI] [PubMed] [Google Scholar]
- Zambelli F, Pesole G, Pavesi G 2009. Pscan: Finding over-represented transcription factor binding site motifs in sequences from co-regulated or co-expressed genes. Nucleic Acids Res 37: W247–W252 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zaret KS, Carroll JS 2011. Pioneer transcription factors: Establishing competence for gene expression. Genes Dev 25: 2227–2241 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zemzoumi K, Frontini M, Bellorini M, Mantovani R 1999. NF-Y histone fold α1 helices help impart CCAAT specificity. J Mol Biol 286: 327–337 [DOI] [PubMed] [Google Scholar]